Biotech

All Articles

Metsera coordinate with Amneal to secure down GLP-1 supply

.With early stage 1 data now out in bush, metabolic ailment ensemble Metsera is actually squandering...

Rivus posts data to back up muscle-sparing obesity medicine cases

.Rivus Pharmaceuticals has unveiled the records behind its own phase 2 weight problems win in heart ...

BMS spends $110M to form T-cell therapy treaty, aiding Top purchase opportunity to develop prioritized pipe

.Bristol Myers Squibb is actually paying Excellent Medicine $110 thousand beforehand to create reage...

Generate gains one more $1B-plus Significant Pharma relationship

.Novartis has tattooed a package likely worth more than $1 billion with Flagship-founded Generate: B...

Metsera GLP-1 data cut exposes 7.5% weight-loss at 36 days

.Recently debuted Metsera is actually unfolding some period 1 record for its GLP-1 receptor agonist,...

Flagship wishes biotechs flock to Mirai to improve hereditary medications

.Amid the hereditary medicines arms nationality, Main Pioneering is introducing a brand new firm to ...

BioAge eyes $180M from IPO, exclusive positioning for excessive weight trials

.BioAge Labs is actually eyeing around $180 thousand in first earnings from an IPO and a private pos...

Merck's LAG-3 combo stops working intestines cancer period 3 research study

.A try through Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic intestines cance...

Spanish VC finalizes $200M life scientific researches fund

.Spain-based Asabys Allies has shut a fund of 180 thousand europeans ($ 200 million), loan that will...

BioAge produces $198M coming from IPO as obesity biotech participates in Nasdaq

.BioAge Labs is actually bringing in virtually $200 thousand via its Nasdaq IPO today, along with th...